CD34 and heart failure: Salvatore et al., studying intracoronary infusion of CD34+ cells in patients with end-stage diffuse CAD who were not candidates for coronary interventional therapy, performed a 5-year follow-up to evaluate the potential of CD34+ cell therapy in improving left ventricular function, heart failure, and cardiac remodeling (140).